Trial intelligence / Profile preview

Insulin Infusion Protocol Using Spreadsheet for Diabetic Ketoacidosis in ICU

TCTR20251021009Phase 3Completed

Sponsor
Supasuta Wongdama
Start
Dec 2021
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of human insulin in diabetic ketoacidosis (DKA) and diabetes mellitus (DM), sponsored by Supasuta Wongdama. Started Dec 2021; status: completed.

02

Drugs

human insulin
03

Conditions

diabetic ketoacidosis (DKA)diabetes mellitus (DM)

Beyond the preview

Go deeper on TCTR20251021009.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20251021009.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call